Adaptive Biotechnologies Enter into Worldwide Collab & LA wGenentech to Develop Personalized Cellular Therapies for the Treatment of Cancer. $300M upfront to Adaptive $RHHBY $ROG httpswww.businesswire.comnewshome20190104005112enAdaptiveBiotechn

Adaptive Biotechnologies Enter into Worldwide Collab & LA w/#Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer. $300M upfront to Adaptive $RHHBY $ROG https://www.businesswire.com/news/home/20190104005112/en/Adaptive-Biotechn

09:17 EST 4 Jan 2019 | Odi Bruckman

Adaptive Biotechnologies Enter into Worldwide Collab & LA w/ #Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer. $300M upfront to Adaptive $RHHBY $ROG https://www.businesswire.com/news/home/20190104005112/en/Adaptive-Biotechnologies-Enter-Worldwide-Collaboration-License-Agreement …

More From BioPortfolio on "Adaptive Biotechnologies Enter into Worldwide Collab & LA w/#Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer. $300M upfront to Adaptive $RHHBY $ROG https://www.businesswire.com/news/home/20190104005112/en/Adaptive-Biotechn"